Clinical Trials
6 trialsNCT06319196 2026-06-04
ClearMe
University Health Network, Toronto
Phase 2 Recruiting
NCT05625399 2026-06-03
RELATIVITY-127
Bristol-Myers Squibb
Phase 3 Active not recruiting
NCT05912244 2026-06-01
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT07281924 2026-05-29
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
University of Wisconsin, Madison
Phase 1/2 Recruiting
NCT06712927 2026-05-18
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
Stanford University
Phase 2 Recruiting
NCT03645928 2026-05-15
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
Iovance Biotherapeutics, Inc.
Phase 2 Terminated